Creative Medical Technology Holdings, Inc. (CELZ): Total Assets
$7.81M
As of 2025-12-31
$9.38M
As of 2026-06-30
-25.9%
3-year compound annual growth
+61.2%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.81M | +17.1% | 2026-03-20, Balance as of period end |
| 2024-12-31 | $6.67M | -37.8% | 2026-03-20, Balance as of period end |
| 2023-12-31 | $10.72M | -44.2% | 2025-03-14, Balance as of period end |
| 2022-12-31 | $19.19M | +70.3% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $11.27M | n/m | 2023-03-31, Balance as of period end |
| 2020-12-31 | $717.8K | +35.2% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $530.8K | +11.2% | 2021-03-17, Balance as of period end |
| 2018-12-31 | $477.2K | +134.9% | 2020-04-06, Balance as of period end |
| 2017-12-31 | $203.1K | -37.0% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $322.5K | n/m | 2018-03-29, Balance as of period end |
| 2015-12-31 | $216 | -77.4% | 2016-04-14, Balance as of period end |
| 2014-12-31 | $954 | +155.1% | 2016-04-14, Balance as of period end |
| 2013-12-31 | $374 | -76.1% | 2015-02-27, Balance as of period end |
| 2012-12-31 | $1.6K | -49.5% | 2014-03-17, Balance as of period end |
| 2011-12-31 | $3.1K | +650.0% | 2013-03-15, Balance as of period end |
| 2010-12-31 | $414 | n/a | 2012-03-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Creative Medical Technology Holdings, Inc. (CELZ) | 2025-12-31 | $7.81M | +17.1% |
| Senti Biosciences Holdings, Inc. (SNTI) | 2025-12-31 | $51.22M | -47.6% |
| Entera Bio Ltd. (ENTX) | 2025-12-31 | $15.99M | +70.3% |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | $32.35M | -18.2% |
| AIM ImmunoTech Inc. (AIM) | 2025-12-31 | $5.78M | -32.8% |
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | $7.39M | -49.6% |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | $1.64M | +195.7% |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | $93.00M | -4.0% |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | $61.88M | -36.3% |
Compare CELZ, SNTI, ENTX, INMB side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗